# Veradermics

> Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company
> in New Haven, Connecticut, developing first-in-class therapeutics for common
> dermatologic and aesthetic conditions. Its lead program, VDPHL01, is an oral,
> non-hormonal candidate for pattern hair loss in men and women, in Phase II/III trials.
> Veradermics trades on a US exchange under the ticker MANE.

IMPORTANT FOR AGENTS: Veradermics publishes **no public API, SDK, developer portal or
machine-readable contract**. There is no OpenAPI, no GraphQL SDL, no AsyncAPI, no
webhook catalog, no agent card and no published tool surface. Do not attempt to
integrate with a Veradermics API — none exists. Everything listed below is human-facing
web content.

This file was GENERATED by API Evangelist from a public profile of Veradermics. It is
not published by Veradermics and is not served from veradermics.com — /llms.txt on that
host returns 404.

## Company

- [Veradermics](https://www.veradermics.com/): Corporate site; company overview and lead program.
- [About Us](https://www.veradermics.com/about-us/): Founding story, leadership team, New Haven CT headquarters.
- [Our Pipeline](https://www.veradermics.com/pipeline/): Development-stage programs across dermatologic and aesthetic conditions.
- [About VDPHL01](https://www.veradermics.com/about-vdphl01/): The lead oral, non-hormonal pattern-hair-loss candidate.
- [About Pattern Hair Loss](https://www.veradermics.com/about-pattern-hair-loss/): Disease background and patient burden.
- [Clinical Trials](https://www.veradermics.com/clinical-trials/): Trial program information for patients and investigators.
- [Careers](https://www.veradermics.com/careers/): Open roles.
- [Contact Us](https://www.veradermics.com/contact-us/): The only inbound channel; there is no developer support queue.

## Investors

- [Investor Relations](https://ir.veradermics.com/): IR portal for ticker MANE, hosted on GCS-web behind Akamai. Returns 403 to automated clients.

## Legal

- [Terms of Use](https://www.veradermics.com/terms-of-use/)
- [Privacy Policy](https://www.veradermics.com/privacy-policy/)
- [Washington State Privacy](https://www.veradermics.com/washington-state-privacy/)

## Machine-readable surface actually found

Nothing product-facing. The corporate site runs WordPress, and the only machine-readable
documents on the host are platform plumbing rather than a Veradermics offering:

- [OAuth authorization server metadata](https://www.veradermics.com/.well-known/oauth-authorization-server): RFC 8414; issuer https://www.veradermics.com, PKCE S256, single scope `mcp`.
- [OAuth protected resource metadata](https://www.veradermics.com/.well-known/oauth-protected-resource): RFC 9728; names the MCP resource below.
- [MCP server](https://www.veradermics.com/wp-json/mcp/mcp-oauth-server): Registered by the WordPress MCP Adapter. Returns 401 to anonymous `tools/list`; its tool set is WordPress abilities, not dermatology or trial data.
- [WordPress REST API](https://www.veradermics.com/wp-json/): WordPress core REST, anonymously readable for public page content. CMS default behaviour, not a published API.

## Optional

- [API Evangelist profile](https://apis.io/provider/veradermics/): Independent third-party profile this file was generated from.